Institut_Gustave-RoussyCategory:Institut_Gustave-Roussy%C3%9Astav_Gustava_RoussyhoInstitut_Gustave_RoussyInstitut_Gustave_RoussyInstitut_Gustave-RoussyInstituto_Gustave_RoussyGustave-Roussy_InstitutuaGustave_Roussy_instituuttiGustave-RoussyInstituto_Gustave-RoussyIstituto_Gustave-RoussyGustave-Roussy_instituutInstitut_Gustave_RoussyInstytut_Gustave-RoussyInstitut_Gustave_RoussyInstitut_Gustave-RoussyInstitut_Gustave_RoussyQ266227%E5%8F%A4%E6%96%AF%E5%A1%94%E5%A4%AB%E9%B2%81%E8%A5%BF%E7%A0%94%E7%A9%B6%E6%89%80
about
Frédéric TriebelLaurence ZitvogelAlexander EggermontYegor VassetzkyNathalie ChaputSylvie RusakiewiczLaura SenovillaMeriem MessaoudeneRomain DaillèreDiane GoereNadège VimondDominique Valteau-CouanetVéronique Minard-ColinFederico RotoloErika VacchelliIsabelle MartinsEric AngevinStefan MichielsFabrice AndréCaroline RobertValérie BoigeStéphane TerryJonathan G PolAurélien MarabelleAndrei SeferianAurélie AugusteElena BaixerasAngela CioffiAntoine HollebecqueBrigitte Bressac-de PailleretsCatherine HillClarisse DromainY BoursinAngela Di GiannataleLaurence AlbigesRakhan AimbetovOlivier MirSophie BroutinWindy Luscap-RondofMeltem Erol
P108
Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney CancerAnti-PD-1 Monoclonal Antibody in Advanced, Trastuzumab-resistant, HER2-positive Breast CancerCohort of Patients With NSCLC Treated With Nivolumab Under the ATU ProgramFRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/PaclitaxelSAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast CancerStudy Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer PatientsImmunization Strategy With Intra-tumoral Injections of Pexa-Vec With Ipilimumab in Metastatic / Advanced Solid Tumors.Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory Breast CancerAn Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 MutationValidation of a Genetic Signature to Predict the Development of SarcomasStudy of a Simplified Geriatric Evaluation Performed by Oncologists Prior to Cancer Treatment by Radiotherapy or Chemotherapy in Subjects Aged 70 Years or Older With Inoperable Squamous Cell Cancer of the Head and NeckMechanistic and Molecular Study of the Process of Metastatic Dissemination in Colorectal CancerTrial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint AtezolizumabNeurocognitive Risks in Children With Solid TumorsMultiparametric PET-MRI Integration for a New Approach to Tumor Heterogeneity in Non-Small Cell Lung Cancer (NSCLC): Pilot StudyStudy of Coronary Calcium Score as a Marker of Post-radiation Vascular Dysplasia in Adults Treated During Childhood for Cancer With Mediastinal IrradiationEvaluation of HPV OncoTect ™ for the Etiological Diagnosis of HPV-induced Oropharyngeal CancersTrial Evaluating and Comparing Two Intensification Treatment Strategies for Metastatic Neuroblastoma Patients With a Poor Response to Induction ChemotherapySULTAN (Improving SUrgery of Liver Metastases: a Trial of the Arterial Chemotherapy Network)Optimized Angiomammography and Comparison With Standard AngiomammographyPhase I/II Study of Neoadjuvant Lapatinib in Breast CancerBevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By SurgerySafety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem GliomaSentinel Lymph Node Technique in Multifocal Breast CancerEndoTAG-1 in Triple Receptor Negative Breast Cancer PatientsProspective Multicentric Randomized Study of Glivec® in Advanced GIST Expressing C-kit: Interruption After 5 Years vs MaintenanceChemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC)LFB-R603 Dose Finding in Patients With Advanced Stage B-Chronic Lymphocytic LeukemiaDecitabine in Patients With Chronic Myelomonocytic Leukemia (CMML)Study of NMS-1116354 in Advanced/Metastatic Solid TumorsStudy of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell LymphomaLIFSCREEN : Evaluation of Whole Body MRI for Early Detection of Cancers in Subjects With P53 Mutation (Li-Fraumeni Syndrome)Pregnant Women With a Breast Cancer Diagnosed Between 2000 and 2014Adjuvant PEG Intron in Ulcerated MelanomaEvaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast CancerEvaluation of Beauty Care Before Chemotherapy in Women With Breast CancerEfficacy and Safety of R-HAD Alone or in Combination With Bortezomib in Patients With Relapsed or Refractory MCLComparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After ProstatectomyBreast Cancer ToxicityA Study of DNIB0600A in Comparison With Pegylated Liposomal Doxorubicin (PLD) in Participants With Platinum-Resistant Ovarian Cancer (PROC)
P6153
Rétrovirus Endogènes et Eléments Rétroides des Eucaryotes SupérieursLaboratory for Vectorology in Anticancer TherapyImagerie par Résonance Magnétique Médicale et Multi-ModalitésGenetic Stability and OncogenesisIntegrative Cancer Immunology and OncogeneticSignalisation, Noyaux et Innovations en Cancérologie
P749
Q21055253-FEFDDEBE-623E-4763-8C37-DCF53A84BCC8Q28317098-a4b96d79-4ce7-04ad-dc58-40d36be4d309Q28317101-9e56c581-4161-b47f-b251-88ee7c9c6fd2Q30430091-442DD365-BAF3-425B-AE70-722BBABE1F61Q37282462-42dbf933-47e5-a0c7-d8ac-b1609d6dd840Q37284788-d8298a42-410f-3fee-4a7c-5273e3b4ad57Q38192735-f4a0c6c9-434b-847c-5c24-e5b5f3bf7f9dQ40255603-473cf84a-4970-40fb-b392-78f88c7dcfd6Q40255955-cd9cc965-4fa9-2492-034d-b33b70edd00dQ40350292-43344b06-4048-be51-89c8-b53c3f4b024bQ40400188-704ecffb-4e0a-a80d-2c3a-2f81457d7029Q40400401-54514099-4cba-1123-347e-6d6e2a55eb89Q40400743-a3ab0d1a-44c2-72f0-45db-f18aa6526a16Q40528389-0F646D23-DFE3-4773-9F55-6E332FD747B0Q40778875-d0af89a9-4f6a-908a-554c-0b6906314d48Q40779307-3c045287-48a2-ec98-843c-1e8f34c6c98cQ40782153-7939f8bc-492a-da08-aa73-747b93008326Q41044549-C42DC00B-1B68-4120-B596-8599AB220988Q41743842-895c2f84-4bfb-ceba-e4c2-9d10b9b10c10Q41784107-934beaab-4be7-1252-6452-cb2e661c910cQ41786186-17E5E6C0-453A-4861-989B-F998BB3A86C6Q42173186-563A27E5-910B-4376-B958-1E18996FA333Q42173411-D89E980B-6A2C-4781-B52A-726386815F82Q42303208-21EB4975-B436-4237-8E3C-0E0E5DD55B00Q42356316-C1F9F918-B3D0-457F-86FF-C2AE2AF37362Q42759076-7BE769B3-D3C7-483C-A0D3-97D88AEB79EAQ42870821-04AD3A0E-A3F5-45D5-B8B5-E517F3B01AB6Q43200541-246A088E-54E6-4E19-ACA4-BE84278C9150Q43200541-AA085A5E-3423-4121-878E-0A7CD22FEC3EQ43212753-EAF475EB-653D-4B93-BEB1-B72590E923AEQ43376253-FECB7883-B7A1-4A6A-AE36-2F7994A80738Q43400522-CA9887CB-753B-4997-A21B-1066A165D9A9Q51192569-561756C9-CEEB-4595-9A0B-09AB57E93D68Q53267146-756E406C-8DC0-4510-8932-3A68244F9A56Q53534626-822FC88A-855D-477E-AA34-F1A2A199CCD8Q53534626-CF6A0E66-FBEA-48E0-A846-D2269F14BDE1Q54553347-fc7cc5b0-4e00-42a6-a427-37c25a431d81Q54611077-4F8ECB21-7C6A-46E8-99BC-EFEF2B8376B9Q55644815-9164AA94-B80A-4E79-8225-E554019ED66EQ56527799-B2129875-D53E-47F7-B8A6-7CBA37775858
P108
Q58407098-42672E14-13E8-4204-A939-0618F4CB535DQ58407579-0D9BE07A-A35C-4076-AC4A-9F555E2713D3Q58407601-88310703-3F26-478B-8252-921F019576C7Q58407864-2AFF0B53-F3FB-45C4-BC8E-60C8AC6A0B20Q58407870-71D9DEA6-7A6D-46FF-952C-0DE8AB04F1C0Q58844775-85A8ABE7-C831-4A42-BA4C-07E67E4D160DQ58845956-27C1E613-177E-42E9-B4D2-B290080526D0Q58850199-8E4CF2A4-6186-49EB-8261-D877AD979DF6Q61862232-34517D2C-A35A-4D91-A901-192086FCC510Q61904381-2986C6D3-229D-45FE-BF13-3CD23BEACF4EQ61904965-C9E563E4-1E76-4F66-A035-E4E411B2B557Q61905039-F2ECC24A-591E-4607-AB9C-119CBD18402FQ61905123-9C69938F-D7F4-4556-AF7E-8CD1F7D502F0Q61906987-5069E8C6-EAF4-4C13-B2F0-8605E60BF477Q61907257-63140245-A704-4423-952E-A425B222986EQ61907385-574437FB-3A2F-4789-AF17-639F153FD8C4Q61907389-5C00F4A5-E43F-41D0-B579-6686B057C0BBQ61908819-29D8F066-E4D2-4AA0-A468-27AF8C63CD06Q61908883-4C7EFEE1-DB48-4401-AF4D-5D5AD0EC644AQ61909668-9039CC93-BAB5-42C8-B7C5-786A5FE375EFQ61921030-C01784E8-0EC7-4BE2-AB32-AEEF328A9C3CQ61921674-048915C6-DF3C-4EDE-B23F-95CDC54C6858Q61922205-AFB1C798-4EE4-4645-A31D-B0DE8ADAE244Q61922289-0D32D28F-62CB-4041-AD11-34CD6C0F97E8Q61923824-BF8B482F-3532-4521-861E-341E628B2C07Q61933819-D56DC9CE-E4C4-47A1-BD39-C1ACE6B3F045Q61935928-23585039-219D-4A74-961F-23FE9D7635A8Q61936344-1E80F240-DD3A-4E39-AF2D-21B49572EC60Q61936355-85667CF7-F6F3-4C46-A611-B5B62A75F3C0Q61937021-8402D682-EF4F-44BF-9253-D4BCF096FECCQ61956261-80671754-B1A5-4C86-8DBF-AD94AD2D3C03Q61956805-85E73E0A-6FCC-4DB5-9C0F-ED44BF8E51AFQ61957444-5DC53917-AC43-4368-84CC-E2ED2DCBE988Q61957476-D07C6BFF-BA7C-4226-BD2D-88CDE2F09B76Q61965724-88B0FBB5-76DE-4A07-A574-933CB251B3EFQ61965825-846FDB86-EB56-4FCF-8743-62955C900DCCQ61967610-2EF7BA85-E392-4DEE-98F3-3E9F1F6671D3Q61969792-C76F5BB9-B1DD-4574-AF16-1CB5AC345282Q61969852-DBC5E711-F915-4CA0-BAD6-AD291DD0ECADQ61970037-152C85BC-34CB-463D-8E2E-5AF1E108E267
P6153
description
centro di ricerca francese
@it
französisches Krankenhaus
@de
griya sakit
@jv
hospital de Francia
@ast
hospital especializado en el tratamiento del cáncer
@es
hospital especializado no tratamento de câncer
@pt
hospital in France
@en
hôpital spécialisé dans le traitement des cancers à Villejuif (France)
@fr
kanser tedavisinde uzmanlaşmış hastane
@tr
rumah sakik
@min
name
Gustave Roussy instituutti
@fi
Gustave-Roussy Institutua
@eu
Institut Gustave Roussy
@de
Institut Gustave Roussy
@en
Institut Gustave Roussy
@nl
Institut Gustave Roussy
@pt
Institut Gustave Roussy
@tr
Institut Gustave-Roussy
@ace
Institut Gustave-Roussy
@ast
Institut Gustave-Roussy
@ca
type
label
Gustave Roussy instituutti
@fi
Gustave-Roussy Institutua
@eu
Institut Gustave Roussy
@de
Institut Gustave Roussy
@en
Institut Gustave Roussy
@nl
Institut Gustave Roussy
@pt
Institut Gustave Roussy
@tr
Institut Gustave-Roussy
@ace
Institut Gustave-Roussy
@ast
Institut Gustave-Roussy
@ca
altLabel
Gustave-Roussy
@ace
Gustave-Roussy
@ast
Gustave-Roussy
@de
Gustave-Roussy
@en
Gustave-Roussy
@es
Gustave-Roussy
@fr
Gustave-Roussy
@he
Gustave-Roussy
@id
Gustave-Roussy
@ja
Gustave-Roussy
@jv
prefLabel
Gustave Roussy instituutti
@fi
Gustave-Roussy Institutua
@eu
Institut Gustave Roussy
@de
Institut Gustave Roussy
@en
Institut Gustave Roussy
@nl
Institut Gustave Roussy
@pt
Institut Gustave Roussy
@tr
Institut Gustave-Roussy
@ace
Institut Gustave-Roussy
@ast
Institut Gustave-Roussy
@ca